Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

Bromopyrrole Alkaloids of the Sponge Agelas oroides Collected Near the Israeli Mediterranean Coastline.

Kovalerchik D, Singh RP, Schlesinger P, Mahajni A, Shefer S, Fridman M, Ilan M, Carmeli S.

J Nat Prod. 2020 Feb 28;83(2):374-384. doi: 10.1021/acs.jnatprod.9b00863. Epub 2020 Feb 19.

PMID:
32072810
2.

Rental Assistance and Adult Self-Rated Health.

Keene DE, Niccolai L, Rosenberg A, Schlesinger P, Blankenship KM.

J Health Care Poor Underserved. 2020;31(1):325-339. doi: 10.1353/hpu.2020.0025.

PMID:
32037334
3.

Quantifying the Restrictiveness of Local Housing Authority Policies Toward People With Criminal Justice Histories: United States, 2009-2018.

Purtle J, Gebrekristos LT, Keene D, Schlesinger P, Niccolai L, Blankenship KM.

Am J Public Health. 2020 Jan;110(S1):S137-S144. doi: 10.2105/AJPH.2019.305437.

4.

Cellular and extracellular matrix of bone, with principles of synthesis and dependency of mineral deposition on cell membrane transport.

Schlesinger PH, Blair HC, Beer Stolz D, Riazanski V, Ray EC, Tourkova IL, Nelson DJ.

Am J Physiol Cell Physiol. 2020 Jan 1;318(1):C111-C124. doi: 10.1152/ajpcell.00120.2019. Epub 2019 Sep 18.

PMID:
31532718
5.

The impact of protected area governance and management capacity on ecosystem function in Central America.

Muñoz Brenes CL, Jones KW, Schlesinger P, Robalino J, Vierling L.

PLoS One. 2018 Oct 18;13(10):e0205964. doi: 10.1371/journal.pone.0205964. eCollection 2018.

6.

Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice.

Pan H, Palekar RU, Hou KK, Bacon J, Yan H, Springer LE, Akk A, Yang L, Miller MJ, Pham CT, Schlesinger PH, Wickline SA.

Int J Nanomedicine. 2018 Sep 6;13:5187-5205. doi: 10.2147/IJN.S168556. eCollection 2018.

7.

Mechanism of High-Level Daptomycin Resistance in Corynebacterium striatum.

Goldner NK, Bulow C, Cho K, Wallace M, Hsu FF, Patti GJ, Burnham CA, Schlesinger P, Dantas G.

mSphere. 2018 Aug 8;3(4). pii: e00371-18. doi: 10.1128/mSphereDirect.00371-18.

8.

Support of bone mineral deposition by regulation of pH.

Blair HC, Larrouture QC, Tourkova IL, Liu L, Bian JH, Stolz DB, Nelson DJ, Schlesinger PH.

Am J Physiol Cell Physiol. 2018 Oct 1;315(4):C587-C597. doi: 10.1152/ajpcell.00056.2018. Epub 2018 Jul 25.

9.

Navigating Limited and Uncertain Access to Subsidized Housing After Prison.

Keene DE, Rosenberg A, Schlesinger P, Guo M, Blankenship KM.

Hous Policy Debate. 2018;28(2):199-214. doi: 10.1080/10511482.2017.1336638. Epub 2017 Jul 31.

10.

Triggered recruitment of ESCRT machinery promotes endolysosomal repair.

Skowyra ML, Schlesinger PH, Naismith TV, Hanson PI.

Science. 2018 Apr 6;360(6384). pii: eaar5078. doi: 10.1126/science.aar5078.

11.

Design, synthesis, and biological evaluation of stable β6.3-Helices: Discovery of non-hemolytic antibacterial peptides.

Reddy DN, Singh S, Ho CMW, Patel J, Schlesinger P, Rodgers S, Doctor A, Marshall GR.

Eur J Med Chem. 2018 Apr 10;149:193-210. doi: 10.1016/j.ejmech.2018.02.057. Epub 2018 Feb 20.

PMID:
29501941
12.

A global reference database of crowdsourced cropland data collected using the Geo-Wiki platform.

Laso Bayas JC, Lesiv M, Waldner F, Schucknecht A, Duerauer M, See L, Fritz S, Fraisl D, Moorthy I, McCallum I, Perger C, Danylo O, Defourny P, Gallego J, Gilliams S, Akhtar IUH, Baishya SJ, Baruah M, Bungnamei K, Campos A, Changkakati T, Cipriani A, Das K, Das K, Das I, Davis KF, Hazarika P, Johnson BA, Malek Z, Molinari ME, Panging K, Pawe CK, Pérez-Hoyos A, Sahariah PK, Sahariah D, Saikia A, Saikia M, Schlesinger P, Seidacaru E, Singha K, Wilson JW.

Sci Data. 2017 Sep 26;4:170136. doi: 10.1038/sdata.2017.136.

13.

Liposome Disruption Assay to Examine Lytic Properties of Biomolecules.

Jimah JR, Schlesinger PH, Tolia NH.

Bio Protoc. 2017 Aug 5;7(15). pii: e2433. doi: 10.21769/BioProtoc.2433.

14.

Membrane Lipid Screen to Identify Molecular Targets of Biomolecules.

Jimah JR, Schlesinger PH, Tolia NH.

Bio Protoc. 2017 Aug 5;7(15). pii: e2427. doi: 10.21769/BioProtoc.2427.

15.

Malaria parasite CelTOS targets the inner leaflet of cell membranes for pore-dependent disruption.

Jimah JR, Salinas ND, Sala-Rabanal M, Jones NG, Sibley LD, Nichols CG, Schlesinger PH, Tolia NH.

Elife. 2016 Dec 1;5. pii: e20621. doi: 10.7554/eLife.20621.

16.

Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.

Blair HC, Larrouture QC, Li Y, Lin H, Beer-Stoltz D, Liu L, Tuan RS, Robinson LJ, Schlesinger PH, Nelson DJ.

Tissue Eng Part B Rev. 2017 Jun;23(3):268-280. doi: 10.1089/ten.TEB.2016.0454. Epub 2016 Dec 27.

17.

The 2015 Gold Medal for Distinguished Service--DR MICHAEL L. STUART.

Callis B, Schlesinger PH.

Tex Dent J. 2015 Nov;132(11):904-9. No abstract available.

PMID:
26845826
18.

Chloride-hydrogen antiporters ClC-3 and ClC-5 drive osteoblast mineralization and regulate fine-structure bone patterning in vitro.

Larrouture QC, Nelson DJ, Robinson LJ, Liu L, Tourkova I, Schlesinger PH, Blair HC.

Physiol Rep. 2015 Nov;3(11). pii: e12607. doi: 10.14814/phy2.12607. Epub 2015 Nov 24.

19.

A novel intrinsically fluorescent probe for study of uptake and trafficking of 25-hydroxycholesterol.

Iaea DB, Gale SE, Bielska AA, Krishnan K, Fujiwara H, Jiang H, Maxfield FR, Schlesinger PH, Covey DF, Schaffer JE, Ory DS.

J Lipid Res. 2015 Dec;56(12):2408-19. doi: 10.1194/jlr.D064287. Epub 2015 Oct 24.

20.

Syringomyelia in a Newborn Male Simmental Calf.

Burgstaller J, Thaller D, Leeb T, Schlesinger P, Kofler J.

J Vet Intern Med. 2015 Nov-Dec;29(6):1633-7. doi: 10.1111/jvim.13646. Epub 2015 Oct 18. No abstract available.

21.

Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles.

Jallouk AP, Palekar RU, Marsh JN, Pan H, Pham CT, Schlesinger PH, Wickline SA.

Bioconjug Chem. 2015 Aug 19;26(8):1640-50. doi: 10.1021/acs.bioconjchem.5b00246. Epub 2015 Jul 2.

22.

A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittin.

Hou KK, Pan H, Schlesinger PH, Wickline SA.

Biotechnol Adv. 2015 Nov 1;33(6 Pt 1):931-40. doi: 10.1016/j.biotechadv.2015.05.005. Epub 2015 May 27. Review.

23.

Modifications of natural peptides for nanoparticle and drug design.

Jallouk AP, Palekar RU, Pan H, Schlesinger PH, Wickline SA.

Adv Protein Chem Struct Biol. 2015;98:57-91. doi: 10.1016/bs.apcsb.2014.12.001. Epub 2015 Mar 12. Review.

24.

Improved Coarse-Grained Modeling of Cholesterol-Containing Lipid Bilayers.

Daily MD, Olsen BN, Schlesinger PH, Ory DS, Baker NA.

J Chem Theory Comput. 2014 May 13;10(5):2137-2150.

25.

Side-chain oxysterols modulate cholesterol accessibility through membrane remodeling.

Bielska AA, Olsen BN, Gale SE, Mydock-McGrane L, Krishnan K, Baker NA, Schlesinger PH, Covey DF, Ory DS.

Biochemistry. 2014 May 13;53(18):3042-51. doi: 10.1021/bi5000096. Epub 2014 May 1.

26.

Tracking the subcellular fate of 20(s)-hydroxycholesterol with click chemistry reveals a transport pathway to the Golgi.

Peyrot SM, Nachtergaele S, Luchetti G, Mydock-McGrane LK, Fujiwara H, Scherrer D, Jallouk A, Schlesinger PH, Ory DS, Covey DF, Rohatgi R.

J Biol Chem. 2014 Apr 18;289(16):11095-110. doi: 10.1074/jbc.M113.540351. Epub 2014 Mar 4.

27.

A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.

Gritsiouk Y, Hegsted DA, Schlesinger P, Gardiner SK, Gubler KD.

Am J Surg. 2014 May;207(5):648-51; discussion 651-2. doi: 10.1016/j.amjsurg.2013.12.010. Epub 2014 Jan 30.

PMID:
24560359
28.

Resident Rounds. Part III. A case of dermatomyositis presenting with eyelid nodules.

Goldfarb N, Lin SW, Jaimes J, Fenyk J, Schlesinger PA.

J Drugs Dermatol. 2013 Dec;12(12):1486-8. No abstract available.

PMID:
24466592
29.

The structural basis of cholesterol accessibility in membranes.

Olsen BN, Bielska AA, Lee T, Daily MD, Covey DF, Schlesinger PH, Baker NA, Ory DS.

Biophys J. 2013 Oct 15;105(8):1838-47. doi: 10.1016/j.bpj.2013.08.042.

30.

Thrombin-targeted liposomes establish a sustained localized anticlotting barrier against acute thrombosis.

Palekar RU, Myerson JW, Schlesinger PH, Sadler JE, Pan H, Wickline SA.

Mol Pharm. 2013 Nov 4;10(11):4168-75. doi: 10.1021/mp400210q. Epub 2013 Oct 10.

31.

Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.

Hou KK, Pan H, Ratner L, Schlesinger PH, Wickline SA.

ACS Nano. 2013 Oct 22;7(10):8605-15. doi: 10.1021/nn403311c. Epub 2013 Sep 26.

32.

Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture.

Hawkins-Salsbury JA, Parameswar AR, Jiang X, Schlesinger PH, Bongarzone E, Ory DS, Demchenko AV, Sands MS.

J Lipid Res. 2013 Dec;54(12):3303-11. doi: 10.1194/jlr.M039610. Epub 2013 Sep 4.

33.

Utility of the risk assessment profile for risk stratification of venous thrombotic events for trauma patients.

Hegsted D, Gritsiouk Y, Schlesinger P, Gardiner S, Gubler KD.

Am J Surg. 2013 May;205(5):517-20; discussion 520. doi: 10.1016/j.amjsurg.2013.01.022.

PMID:
23592157
34.

The 2012 Gold Medal for Distinguished Service--Dr. Patricia L. Blanton, DDS, PhD.

Scott N, Schlesinger PH.

Tex Dent J. 2012 Nov;129(11):1174-7. No abstract available.

PMID:
23487889
35.

Programmable nanoparticle functionalization for in vivo targeting.

Pan H, Myerson JW, Hu L, Marsh JN, Hou K, Scott MJ, Allen JS, Hu G, San Roman S, Lanza GM, Schreiber RD, Schlesinger PH, Wickline SA.

FASEB J. 2013 Jan;27(1):255-64. doi: 10.1096/fj.12-218081. Epub 2012 Oct 9.

36.

Simulation of fusion-mediated nanoemulsion interactions with model lipid bilayers.

Lee SJ, Schlesinger PH, Wickline SA, Lanza GM, Baker NA.

Soft Matter. 2012 Jan 1;8(26):3024-3035. Epub 2012 May 17.

37.

Postformulation peptide drug loading of nanostructures.

Pan H, Marsh JN, Christenson ET, Soman NR, Ivashyna O, Lanza GM, Schlesinger PH, Wickline SA.

Methods Enzymol. 2012;508:17-39. doi: 10.1016/B978-0-12-391860-4.00002-1.

38.

Oxysterols as non-genomic regulators of cholesterol homeostasis.

Bielska AA, Schlesinger P, Covey DF, Ory DS.

Trends Endocrinol Metab. 2012 Mar;23(3):99-106. doi: 10.1016/j.tem.2011.12.002. Epub 2012 Jan 11.

39.

Oxysterols are allosteric activators of the oncoprotein Smoothened.

Nachtergaele S, Mydock LK, Krishnan K, Rammohan J, Schlesinger PH, Covey DF, Rohatgi R.

Nat Chem Biol. 2012 Jan 8;8(2):211-20. doi: 10.1038/nchembio.765.

40.

Interaction of melittin peptides with perfluorocarbon nanoemulsion particles.

Lee SJ, Schlesinger PH, Wickline SA, Lanza GM, Baker NA.

J Phys Chem B. 2011 Dec 29;115(51):15271-9. doi: 10.1021/jp209543c. Epub 2011 Dec 6.

41.

Side-chain oxysterols: from cells to membranes to molecules.

Olsen BN, Schlesinger PH, Ory DS, Baker NA.

Biochim Biophys Acta. 2012 Feb;1818(2):330-6. doi: 10.1016/j.bbamem.2011.06.014. Epub 2011 Jul 1. Review.

42.

Calcium and bone disease.

Blair HC, Robinson LJ, Huang CL, Sun L, Friedman PA, Schlesinger PH, Zaidi M.

Biofactors. 2011 May-Jun;37(3):159-67. doi: 10.1002/biof.143. Epub 2011 Jun 14. Review.

43.

High capacity Na+/H+ exchange activity in mineralizing osteoblasts.

Liu L, Schlesinger PH, Slack NM, Friedman PA, Blair HC.

J Cell Physiol. 2011 Jun;226(6):1702-12. doi: 10.1002/jcp.22501.

44.

25-Hydroxycholesterol increases the availability of cholesterol in phospholipid membranes.

Olsen BN, Schlesinger PH, Ory DS, Baker NA.

Biophys J. 2011 Feb 16;100(4):948-56. doi: 10.1016/j.bpj.2010.12.3728.

45.

Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47.

Frazier EP, Isenberg JS, Shiva S, Zhao L, Schlesinger P, Dimitry J, Abu-Asab MS, Tsokos M, Roberts DD, Frazier WA.

Matrix Biol. 2011 Mar;30(2):154-61. doi: 10.1016/j.matbio.2010.12.004. Epub 2011 Jan 20.

46.

Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.

Pan H, Soman NR, Schlesinger PH, Lanza GM, Wickline SA.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 May-Jun;3(3):318-27. doi: 10.1002/wnan.126. Epub 2011 Jan 10. Review.

PMID:
21225660
47.

Post-formulation peptide drug loading of nanostructures for metered control of NF-κB signaling.

Pan H, Ivashyna O, Sinha B, Lanza GM, Ratner L, Schlesinger PH, Wickline SA.

Biomaterials. 2011 Jan;32(1):231-8. doi: 10.1016/j.biomaterials.2010.08.080.

48.

Characterization of perfluorooctylbromide-based nanoemulsion particles using atomistic molecular dynamics simulations.

Lee SJ, Olsen B, Schlesinger PH, Baker NA.

J Phys Chem B. 2010 Aug 12;114(31):10086-96. doi: 10.1021/jp103228c.

49.

Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures.

Pan H, Myerson JW, Ivashyna O, Soman NR, Marsh JN, Hood JL, Lanza GM, Schlesinger PH, Wickline SA.

FASEB J. 2010 Aug;24(8):2928-37. doi: 10.1096/fj.09-153130. Epub 2010 Mar 24.

50.

Her4 and Her2/neu tyrosine kinase domains dimerize and activate in a reconstituted in vitro system.

Monsey J, Shen W, Schlesinger P, Bose R.

J Biol Chem. 2010 Mar 5;285(10):7035-44. doi: 10.1074/jbc.M109.096032. Epub 2009 Dec 18.

Supplemental Content

Loading ...
Support Center